Loading clinical trials...
Loading clinical trials...
Pharmacokinetic/Pharmacodynamic Effects of add-on Antiplatelet Therapy With Parenteral Cangrelor as Compared to Standard Dual Antiplatelet Treatment in Patients With ST-elevation Myocardial Infarction Complicated by Out-of-hospital Cardiac Arrest and Treated With Targeted Temperature Management
Conditions
Interventions
Cangrelor
Placebo
+2 more
Locations
1
Austria
Medical University of Vienna
Vienna, Austria
Start Date
September 1, 2017
Primary Completion Date
May 1, 2021
Completion Date
December 1, 2021
Last Updated
September 13, 2017
NCT07283809
NCT07157670
NCT03138473
NCT05079724
NCT04000490
NCT04440111
Lead Sponsor
Medical University of Vienna
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions